An overview of acute stroke therapy: past, present, and future.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Archives of Internal Medicine

• Publication date

  2000-11-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.160.21.3196PMID 11088079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.

  2000cited by this paper
• Intravenous Brain-Derived Neurotrophic Factor Reduces Infarct Size and Counterregulates Bax and Bcl-2 Expression After Temporary Focal Cerebral Ischemia

  2000cited by this paper
• Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

  2000cited by this paper
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

  2000cited by this paper
• Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging

  2000cited by this paper
• A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage.

  1999cited by this paper
• Osteogenic protein-1 protects against cerebral infarction induced by MCA ligation in adult rats.

  1999cited by this paper
• Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat

  1999cited by this paper
• A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage.

  1999cited by this paper
• Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia.

  1999cited by this paper
• vator for acute ischemic stroke : feasibility , safety , and efficacy in the first year of clinical practice

  1999cited by this paper
• Neuroprotection of Acute Ischemic Stroke: Where are We?

  1999cited by this paper
• A randomized efficacy trial of citicoline in patients with acute ischemic stroke.

  1999cited by this paper
• Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI.

  1999cited by this paper
• Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model.

  1999cited by this paper
• Inducible nitric oxide synthase expression in human cerebral infarcts

  1999cited by this paper
• Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

  1999cited by this paper
• Applications of diffusion–perfusion magnetic resonance imaging in acute ischemic stroke

  1999cited by this paper
• Acute reorganization of the forepaw representation in the rat SI cortex after focal cortical injury: neuroprotective effects of piracetam treatment

  1999cited by this paper
• Ebselen in Acute Middle Cerebral Artery Occlusion: A Placebo-Controlled, Double-Blind Clinical Trial

  1999cited by this paper
• Thrombolysis in acute ischemic stroke: controlled trials and clinical experience.

  1999cited by this paper
• Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats

  1999cited by this paper
• Attenuation of Delayed Neuronal Death after Mild Focal Ischemia in Mice by Inhibition of the Caspase Family

  1998cited by this paper
• Clomethiazole Acute Stroke Study (CLASS) Results of a Randomized, Controlled Trial of Clomethiazole Versus Placebo in 1360 Acute Stroke Patients

  1998cited by this paper
• Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

  1998cited by this paper
• Lubeluzole protects hippocampal neurons from excitotoxicity in vitro and reduces brain damage caused by ischemia.

  1998cited by this paper
• Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage

  1998cited by this paper
• Prolonged Therapeutic Window for Ischemic Brain Damage Caused by Delayed Caspase Activation

  1998cited by this paper
• Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke

  1998cited by this paper
• Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI

  1998cited by this paper
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma.

  1998cited by this paper
• The expression of P- and E-selectins in three models of middle cerebral artery occlusion.

  1998cited by this paper
• Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based Approach

  1998cited by this paper
• Cardiovascular Safety of Lubeluzole (Prosynap®) in Patients with Ischemic Stroke

  1998cited by this paper
• A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.

  1998cited by this paper
• The Selective Inhibitor of Neuronal Nitric Oxide Synthase, 7-Nitroindazole, Reduces the Delayed Neuronal Damage Due to Forebrain Ischemia in Rats

  1998cited by this paper
• Ebselen in Acute Ischemic Stroke

  1998cited by this paper
• Neuroprotective Agents and Cerebral Ischaemia

  1998cited by this paper
• Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats.

  1998cited by this paper
• Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke.

  1998cited by this paper
• Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

  1998cited by this paper
• Differences in stroke between white, Hispanic, and Native American patients: the Barrow Neurological Institute stroke database.

  1998cited by this paper
• Cerebroprotective Effect of the Nitric Oxide Synthase Inhibitors, 1-(2-Trifluoromethylphenyl) Imidazole and 7-Nitro Indazole, after Transient Focal Cerebral Ischemia in the Rat

  1998cited by this paper
• Intracisternal osteogenic protein‐1 enhances functional recovery following focal stroke

  1998cited by this paper
• Multinational Randomised Controlled Trial of Lubeluzole in Acute Ischaemic Stroke

  1998cited by this paper
• Calcium in ischemic cell death.

  1998cited by this paper
• The selective inhibitor of neuronal nitric oxide synthase, 7-nitroindazole, reduces the delayed neuronal damage due to forebrain ischemia in rats.

  1998cited by this paper
• Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.

  1998cited by this paper
• Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon.

  1998cited by this paper
• Early intravenous thrombolysis for acute ischemic stroke in a community-based approach.

  1998cited by this paper
• Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed.

  1997cited by this paper
• Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction.

  1997cited by this paper
• Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages.

  1997cited by this paper
• Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene

  1997cited by this paper
• Intraventricular Brain-Derived Neurotrophic Factor Reduces Infarct Size after Focal Cerebral Ischemia in Rats

  1997cited by this paper
• Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage

  1997cited by this paper
• Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.

  1997cited by this paper
• Citicoline improves memory performance in elderly subjects.

  1997cited by this paper
• Neuroprotective efficacy of ebselen, an anti‐oxidant with anti‐inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion

  1997cited by this paper
• Characterizing the target of acute stroke therapy.

  1997cited by this paper
• A randomized dose-response trial of citicoline in acute ischemic stroke patients

  1997cited by this paper
• Glycine site antagonist attenuates infarct size in experimental focal ischemia. Postmortem and diffusion mapping studies.

  1997cited by this paper
• Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine.

  1997cited by this paper
• Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats.

  1997cited by this paper
• GABA and neuroprotection.

  1997cited by this paper
• Termination of Acute Stroke Studies Involving Selfotel Treatment

  1997cited by this paper
• Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL.

  1997cited by this paper
• Open label tissue plasminogen activator for stroke: the Oregon experience.

  1997cited by this paper
• Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury.

  1997cited by this paper
• Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.

  1997cited by this paper
• Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial.

  1997cited by this paper
• Cerestat and other NMDA antagonists in ischemic stroke

  1997cited by this paper
• Treatment of Acute Ischemic Stroke With Piracetam

  1997cited by this paper
• Characterizing the Target of Acute Stroke Therapy

  1997cited by this paper
• Lubeluzole Treatment of Acute Ischemic Stroke

  1997cited by this paper
• Intracisternal Basic Fibroblast Growth Factor (bFGF) Enhances Behavioral Recovery following Focal Cerebral Infarction in the Rat

  1996cited by this paper
• Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging.

  1996cited by this paper
• Cerebroprotective effects of aminoguanidine in a rodent model of stroke.

  1996cited by this paper
• Neuroprotective Effects of Human Recombinant Interleukin-1 Receptor Antagonist in Focal Cerebral Ischaemia in the Rat

  1996cited by this paper
• E-selectin appears in nonischemic tissue during experimental focal cerebral ischemia.

  1996cited by this paper
• Periinfarct depolarizations.

  1996cited by this paper
• The effects of prolonged treatment with citicoline in temporary experimental focal ischemia.

  1996cited by this paper
• Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat.

  1996cited by this paper
• Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression.

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Effect of early treatment with tirilazad (U74006F) combined with delayed thrombolytic therapy in rat embolic stroke

  1996cited by this paper
• Chapter 10 GABA and Neuroprotection

  1996cited by this paper
• Citicoline improves verbal memory in aging.

  1996cited by this paper
• Treatment of experimental focal ischemia in rats with lubeluzole.

  1996cited by this paper
• Citicoline for treatment of experimental focal ischemia: histologic and behavioral outcome.

  1996cited by this paper
• Reorganization of movement representations in primary motor cortex following focal ischemic infarcts in adult squirrel monkeys.

  1996cited by this paper
• Neural Substrates for the Effects of Rehabilitative Training on Motor Recovery After Ischemic Infarct

  1996cited by this paper
• Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

  1995cited by this paper
• A Randomized, Double‐Blind, Placebo‐Controlled Pilot Trial of Intravenous Magnesium Sulfate in Acute Stroke

  1995cited by this paper
• Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy

  1995cited by this paper
• Cytokines and the nervous system II: Actions and mechanisms of action.

  1995cited by this paper
• The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat.

  1995cited by this paper

• Research progress of active compounds from traditional Chinese medicine in the treatment of stroke.

  2025cites this paper
• Cerebral hypoperfusion due to rapid blood pressure control in a patient with type B aortic dissection: A case report

  2025cites this paper
• Uncovering a new mechanism of ischemic stroke: a study of the association between γδ T cells and immunoinflammation

  2025cites this paper
• Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates

  2023cites this paper
• Wearable sensors and machine learning in post-stroke rehabilitation assessment: A systematic review

  2022cites this paper
• SETD3 Downregulation Mediates PTEN Upregulation-Induced Ischemic Neuronal Death Through Suppression of Actin Polymerization and Mitochondrial Function

  2021cites this paper
• The Role of the ACE2/MasR Axis in Ischemic Stroke: New Insights for Therapy

  2021cites this paper
• The effects of memantine on the serum concentrations of matrix metalloproteinases and neurologic function of patients with ischemic stroke.

  2021cites this paper
• The Role of Circular RNAs in Brain Injury.

  2020cites this paper
• Early amantadine treatment reduces the risk of death in patients with large hemisphere infarctions:a Chinese hospital-based study

  2020cites this paper
• miR-652 protects rats from cerebral ischemia/reperfusion oxidative stress injury by directly targeting NOX2.

  2020cites this paper
• Expansion of the dimensions in the current management of acute ischemic stroke

  2020cites this paper
• Clinical Efficacy of Tonic Traditional Chinese Medicine Injection on Acute Cerebral Infarction: A Bayesian Network Meta-Analysis

  2020cites this paper
• Anti-embolic and anti-oxidative effects of a novel (E)-4-amino-N′-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against isoproterenol and vitamin-K induced ischemic stroke

  2019cites this paper
• Non-coding RNA and neuroinflammation: implications for the therapy of stroke

  2019cites this paper
• Activation of Sigma-1 Receptor Enhanced Pericyte Survival via the Interplay Between Apoptosis and Autophagy: Implications for Blood–Brain Barrier Integrity in Stroke

  2019cites this paper
• Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review

  2019cites this paper
• Translationally relevant transcriptomic alterations in mouse ischemic cerebral microvessels

  2019cites this paper
• Discovery of Neuroprotective Antioxidants for the Management of Ischemic Brain Stroke

  2018cites this paper
• The JAK 2 / STAT 3 pathway mediates geranylgeranylacetone-induced neuroprotection against cerebral infarction in rats

  2018cites this paper
• Claudin-1-Dependent Destabilization of the Blood–Brain Barrier in Chronic Stroke

  2018cites this paper
• Circular RNA DLGAP4 Ameliorates Ischemic Stroke Outcomes by Targeting miR-143 to Regulate Endothelial-Mesenchymal Transition Associated with Blood–Brain Barrier Integrity

  2018cites this paper
• Effectiveness and safety of ShenXiong glucose injection for acute ischemic stroke: a systematic review and GRADE approach

  2016cites this paper
• Neuroprotection Following Stroke in the Gyrencephalic Non-Human Primate Brain

  2016cites this paper
• THE STUDY OF BIOMARKER HOMOCYSTEINE AS RISK FACTOR IN ACUTE CEREBRAL STROKE PATIENTS OF WESTERN RAJASTHAN

  2016cites this paper
• Granulocyte-Colony Stimulating Factor Increases Cerebral Blood Flow via a NO Surge Mediated by Akt/eNOS Pathway to Reduce Ischemic Injury

  2015cites this paper
• Autophagy biomarkers in CSF correlates with infarct size, clinical severity and neurological outcome in AIS patients

  2015cites this paper
• Developments in Neurovascular Diseases and Treatments

  2015cites this paper
• The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders

  2015cites this paper
• Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke

  2015cites this paper
• Neuroprotektive Wirkmechanismen von Ceftriaxon

  2015cites this paper
• Study on Association between Serum Bilirubin and Acute Ischemic Stroke and Its Prognostic Significance

  2015cites this paper
• THE EFFECT OF MECHANICAL CONTROL OF BRAIN BLOOD FLOW ON THE EMBOLIC MODEL OF STROKE AFTER DELAYED TISSUE PLASMINOGEN ACTIVATOR THERAPY IN OVARIECTOMIZED RAT

  2014cites this paper
• INTERNATIONAL JOURNAL OF PHARMACOLOGY AND THERAPEUTICS

  2014cites this paper
• Novel Therapeutic Strategies for Traumatic Brain Injury: Acute Antioxidant Reinforcement

  2014cites this paper
• Mauritius , Kuthpady , Udupi-574118 Reduit , Karnataka ( INDIA ) Mauritius

  2014cites this paper
• Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats

  2014cites this paper
• Resveratrol alleviates oxidative stress and inflammation in the hippocampus of rats subjected to global cerebral ischemia/reperfusion: Comparison with vitamin E

  2014cites this paper
• A feasible strategy for focal cerebral ischemia-reperfusion injury: remote ischemic postconditioning

  2014cites this paper
• Study of Neuron – Specific Enolase as Potential Biomarker for Assessing the Severity and Outcome in Patients with Cerebrovascular Accidents

  2014cites this paper
• Global cerebral ischemia: synaptic and cognitive dysfunction.

  2013cites this paper
• Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance

  2013cites this paper
• Cortical organotypic slice cultures as a tool to analyze the neurovascular unit in hypoxia/ischemia and hypothermia-induced neuroprotection

  2013cites this paper
• Neuroprotective Effect of Flavonoids in Global Cerebral Ischemic Conditions

  2012cites this paper
• Effect of erythropoietin on Glasgow Coma Scale and Glasgow Outcome Sale in patient with diffuse axonal injury

  2012cites this paper
• Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?

  2012cites this paper
• Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke

  2012cites this paper
• Transient Focal Cerebral Ischemia Induces Long-term Cerebral Vasculature Dysfunction in a Rodent Experimental Stroke Model

  2012cites this paper
• Sevoflurane and Isoflurane Preconditioning Provides Neuroprotection by Inhibition of Apoptosis-related mRNA Expression in a Rat Model of Focal Cerebral Ischemia

  2012cites this paper
• Imaging of stroke: Part 2, Pathophysiology at the molecular and cellular levels and corresponding imaging changes.

  2012cites this paper
• Gene interference regulates aquaporin-4 expression in swollen tissue of rats with cerebral ischemic edema

  2012cites this paper
• Therapeutic imaging window of cerebral infarction revealed by multisequence magnetic resonance imaging: An animal and clinical study

  2012cites this paper
• Long Term Cost-of-Illness in Stroke

  2012cites this paper
• Traditional eating habits and level of homocysteine in the acute first-ever ischaemic stroke

  2012cites this paper
• Therapeutic time window of YGY-E neuroprotection of cerebral ischemic injury in rats.

  2011cites this paper
• Efeitos da terapia com células-tronco mesenquimais em ratos Wistar submetidos à isquemia focal e tratamento de reabilitação

  2011cites this paper
• Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons

  2011cites this paper
• Failure in developing effective treatment for cerebral ischemia: The stair recommendations

  2011cites this paper
• Therapeutic potential of herbal drugs in cerebral ischemia.

  2010cites this paper
• Protective Effect of Post-Ischaemic Viral Delivery of Heat Shock Proteins in vivo

  2009cites this paper
• Salivary neuron specific enolase: an indicator for neuronal damage in patients with ischemic stroke and stroke-prone patients

  2009cites this paper
• Efeito neuroprotetor do anestésico propofol em fatias de hipocampo de ratos submetidos à isquemia cerebral in vitro

  2009cites this paper
• Acanthopanax for acute ischaemic stroke.

  2009cites this paper
• Homocysteine--risk factor for ischemic stroke?

  2009cites this paper
• IGF‐1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions

  2009influential citation
• Entwicklungen neuer Therapiemöglichkeiten des Schlaganfalls

  2008cites this paper
• The effect of two novel C-type lectins, Ba100 and Ba25, isolated from the venom of the puff adder, Bitis arietans on T lymphocyte proliferative responses

  2008cites this paper
• Failure Is the Mother of Success : Why Neuroprotective Therapies That Work in Laboratories Fail in Clinical Trials

  2008cites this paper
• A comparative study on oxidative stress and antioxidant status in ischemic stroke patients with and without diabetes

  2008cites this paper
• Puerarin for acute ischaemic stroke.

  2008cites this paper
• PLASMA AND CEREBROSPINAL FLUID HOMOCYSTEINE, NITRIC OXIDE AND MALONDIALDEHYDE LEVELS IN ACUTE ISCHEMIC STROKE: POSSIBLE ROLE OF FREE RADICALS IN THE DEVELOPMENT OF BRAIN INJURY

  2008cites this paper
• Combination drug therapy using edaravone and Daio-Orengedoku-to after transient focal ischemia in rats.

  2008cites this paper
• Principles of Endovascular Therapy

  2008cites this paper
• PP2, a potent inhibitor of Src family kinases, protects against hippocampal CA1 pyramidal cell death after transient global brain ischemia.

  2007cites this paper
• Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats.

  2007cites this paper
• Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.

  2007cites this paper
• Emerging Therapies for Acute Ischemic Stroke

  2007cites this paper
• Increased Lipid Peroxidation and Decreased Antioxidant Response in Serum and Cerebrospinal Fluid in Acute Ischemic Stroke

  2007cites this paper
• New Pathways for Evaluating Potential Acute Stroke Therapies

  2006cites this paper
• Emerging pharmacotherapeutic strategies for the treatment of ischemic stroke

  2006cites this paper
• [Therapeutically induced arteriogenesis in the brain. A new approach for the prevention of cerebral ischemia with vascular stenosis].

  2006cites this paper
• L-type calcium channels.

  2006cites this paper
• Stroke: epidemiology, classification, risk factors, complications, diagnosis, prevention, and medical and dental management.

  2006cites this paper
• Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.

  2006cites this paper
• NF-κB protects neurons from ischemic injury after middle cerebral artery occlusion in mice

  2006cites this paper
• Therapeutisch induzierte Arteriogenese im Gehirn

  2006cites this paper
• Optimising Clinical Trial Design for Proof of Neuroprotection in Acute Ischaemic Stroke: The SAINT Clinical Trial Programme

  2006cites this paper
• Neuroprotective effect of Acorus calamus against middle cerebral artery occlusion–induced ischaemia in rat

  2006cites this paper
• Practical applications of snake venom toxins in haemostasis.

  2005cites this paper
• Cerebrospinal fluid may mediate CNS ischemic injury

  2005cites this paper
• Disease-oriented Genome Networks Diseases of the Nervous System Network : Genomic Mechanisms of Functional Recovery from Stroke Project : Genomic Mechanisms of Plasticity Evoked by Pro-rehabilitative Means : Voluntary vs . Forced Training

  2005cites this paper
• Why have neuro-protectants failed?: lessons learned from stroke trials.

  2005cites this paper
• The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.

  2005cites this paper
• The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis.

  2005cites this paper
• Why have neuroprotectants failed?

  2005cites this paper
• [Assessment and explorations on the mechanism of neuroprotection of patients in ischemic stroke by traditional Chinese medicine].

  2005cites this paper
• [From bench to bedside: should we believe in the efficacy of stem cells in cerebral ischaemia?].

  2005cites this paper
• The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction.

  2005cites this paper
• Investigational anti-inflammatory agents for the treatment of ischaemic brain injury

  2005cites this paper
• Farmacología de la prevención y el tratamiento del ictus

  2005cites this paper